Limpens J, Scheper R J
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
Clin Exp Immunol. 1991 Jun;84(3):383-8.
In previous work, we have shown that local administration of active cyclophosphamide (CY) derivatives, or other cytostatic drugs, at the sensitization site induced a similar immunopotentiation to that of systemic CY. Since it is well documented that CY can inhibit suppressor cells, it was proposed that immunoenhancement by locally administered drugs might be based on a similar principle. The objective of the present study was to test this hypothesis, using an experimental model of Ts mediated suppression of delayed type hypersensitivity to sheep erythrocytes. In this model, mice are made tolerant to sheep erythrocytes by i.v. injection of a high dose of sheep erythrocytes. Local treatment of sheep erythrocytes-tolerant mice with the active CY derivative Z7557 at the site of attempted sensitization reversed suppression in a dose-dependent manner. Local treatment with the cytostatic drug etoposide (VP-16) and systemic CY treatment were also effective. In transfer experiments, the function of afferently acting suppressor cells was blocked by local treatment with Z7557 or systemic CY. These data support the concept of anti-suppressor cell activity of locally administered cytostatic drugs. As with CY, the pharmacological basis of this effect remains to be determined.
在之前的研究中,我们已经表明,在致敏部位局部给予活性环磷酰胺(CY)衍生物或其他细胞抑制药物,可诱导出与全身应用CY相似的免疫增强作用。由于有充分的文献记载CY可抑制抑制性细胞,因此有人提出,局部给药药物的免疫增强作用可能基于类似的原理。本研究的目的是使用Ts介导的对绵羊红细胞迟发型超敏反应抑制的实验模型来验证这一假设。在该模型中,通过静脉注射高剂量的绵羊红细胞使小鼠对绵羊红细胞产生耐受性。在试图致敏的部位用活性CY衍生物Z7557对绵羊红细胞耐受小鼠进行局部治疗,可呈剂量依赖性地逆转抑制作用。用细胞抑制药物依托泊苷(VP-16)进行局部治疗和全身应用CY治疗也有效。在转移实验中,Z7557局部治疗或全身应用CY可阻断传入性抑制细胞的功能。这些数据支持局部给药细胞抑制药物具有抗抑制细胞活性的概念。与CY一样,这种作用的药理学基础仍有待确定。